These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6177408

  • 1. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
    Bajetta E, Rovej R, Buzzoni R, Vaglini M, Bonadonna G.
    Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
    [Abstract] [Full Text] [Related]

  • 2. Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.
    Nathanson L, Wittenberg BK.
    Cancer Treat Rep; 1980 Jan; 64(1):133-7. PubMed ID: 6155208
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group.
    Johnson DH, Presant C, Einhorn L, Bartolucci AA, Greco FA.
    Cancer Treat Rep; 1985 Jan; 69(7-8):821-4. PubMed ID: 2410120
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
    Creagan ET, Ahmann DL, Schutt AJ, Green SJ.
    Cancer Treat Rep; 1982 Mar; 66(3):567-9. PubMed ID: 6174231
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A, Perrone MA, Michiara M, Delnevo D, Franciosi V, Di Blasio B, Ceci G, Camisa R, Ardizzoni A, Cocconi G.
    Cancer; 2005 May 15; 103(10):2109-17. PubMed ID: 15803492
    [Abstract] [Full Text] [Related]

  • 9. Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammineplatinum(II) in disseminated nonseminomatous testicular cancer.
    Scheulen ME, Seeber S, Schilcher RB, Meier CR, Schmidt CG.
    Cancer Treat Rep; 1980 May 15; 64(4-5):599-609. PubMed ID: 6159077
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
    Atzpodien J, Morawek L, Fluck M, Reitz M.
    Cancer Chemother Pharmacol; 2009 Oct 15; 64(5):901-5. PubMed ID: 19229537
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin, vinblastine and bleocin in the treatment of disseminated testicular cancer.
    Koynov KD, Tzekova VI, Velikova MT.
    Int Urol Nephrol; 1993 Oct 15; 25(4):389-94. PubMed ID: 7506242
    [Abstract] [Full Text] [Related]

  • 13. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
    Cohen SM, Ohnuma T, Ambinder EP, Holland JF.
    Cancer Treat Rep; 1986 May 15; 70(5):688-9. PubMed ID: 2423239
    [No Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
    Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J.
    J Urol; 1998 Nov 15; 160(5):1770-4. PubMed ID: 9783949
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.